Skip to main content
SpringerLink
Log in

The inhibitory effect of human interferon α on the generation of lymphokine-activated killer activity

  • Original articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

The generation of lymphokine-activated killer (LAK) activity and the proliferative response to human recombinant interleukin-2 (IL-2) were significantly reduced by the presence of human recombinant leukocyte interferon (IFNα) in cultures of human peripheral blood mononuclear cells (PBMC). Mature natural killer (NK) cells can be depleted from PBMC with the toxic lysosomotropic agentl-leucine methyl ester. The generation of cytotoxic cells from lymphocytes depleted in leucine methyl ester was also inhibited by indicating that the IFN-α effect is not limited to mature cytotoxic NK cells. Depletion of adherent cells from PBMC did not affect the suppression of LAK induction by IFN-α. Surface marker analyses of Tac antigen and transferrin receptor (TfR) showed that the presence of IFNα throughout the culture period significantly suppressed the typical increase in IL-2-induced Tac- and TfR-positive cells. In contrast, IFNα treatment before and after IL-2 culture enhanced LAK cytotoxic activity. Therefore, combinations of these biological response modifiers for clinical use should take into account the dual effect of IFNα on key features of the IL-2 response.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Besancon F, Bourgeade M, Ugo T (1985) Inhibition of transferrin receptor expression by interferon-α in human lymphoblastoid cells and mitogen-induced lymphocytes. J Biol Chem 260: 13074

    Google Scholar 

  2. Blomgren H, Strander H, Cantell K (1974) Effect of human leukocyte interferon on the response of lymphocytes to mitogenic stimuli in vitro. Scand J Immunol 3: 697

    Google Scholar 

  3. Brunda MJ, Tarnowski D, Davetelis V (1986) Interaction of recombinant interferons with recombinant interleukin-2: differential effects on natural killer cell activity and interleukin-2-activated killer cells. Int J Cancer 37: 787

    Google Scholar 

  4. Karavodin L, Golub SH (1983) Universal rosetting reagent for the detection of human cell surface markers. J Immunol Methods 61: 293

    Google Scholar 

  5. Devos R, Plaetinck G, Cheroutre H, Simons G, Degrave W, Tavernier J, Remaut E, Fiers W (1983) Molecular cloning of human interleukin 2 cDNA and its expression inE. coli. Nucleic Acid Res 11: 4307

    Google Scholar 

  6. Einat M, Resnitzky D, Kimchi A (1985) Close link between reduction of c-myc expression by interferon and G0/G1 arrest. Nature 313: 597

    Google Scholar 

  7. Goeddel DV, Yelverton E, Ullrich A, Heyneker HL, Miozzari G, Holmes W, Seeburg PH, Dull T, May L, Stebbing N, Crea R, Maeda S, McCandliss R, Sloma A, Tabor JM, Gross M, Familletti PC, Pestka S (1980) Human leukocyte interferon produced bye. coli is biologically active. nature 287: 411

    Google Scholar 

  8. Golub SH, Dorey F, Hara D, Morton DL, Burk MW (1982) Systemic administration of human leukocyte interferon to melanoma patients. I. Effects on natural killer function and cell population. J Natl Cancer Inst 68: 703

    Google Scholar 

  9. Golub SH, D'Amore PJ, Rainey M (1982) Systemic administration of human leukocyte interferon to melanoma patients. II. Cellular events associated with changes in natural killer cytotoxicity. J Natl Cancer Inst 68: 711

    Google Scholar 

  10. Gray JD, Shau H, Golub SH (1985) Functional studies on the precursors of human lymphokine-activated killer cells. Cell Immunol 96: 338

    Google Scholar 

  11. Grimm EA, Mazumder A, Zhang HZ, Rosenberg SA (1982) Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J Exp Med 155: 1823

    Google Scholar 

  12. Grimm EA, Robb RJ, Roth JA, Neckers LM, Lachman LB, Wilson DJ, Rosenberg SA (1983) Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells. J Exp Med 158: 1356

    Google Scholar 

  13. Hammer SM, Gillis JM (1986) Effects of recombinant interleukin-2 on resting human T lymphocytes. J Biol Response Mod 5: 36

    Google Scholar 

  14. Heron I, Berg K, Cantell K (1976) Regulatory effect of interferon on T cells in vitro. J Immunol 117: 1370

    Google Scholar 

  15. Hokland P, Hokland M, Olesen BK, Ernest P (1984) Effect of recombinant alpha interferon on NK and ADCC function in lung cancer patients: results from a phase II trial. J Interferon Res 4: 561

    Google Scholar 

  16. Ibayashi Y, Hoon DSB, Golub SH (1987) The regulatory effect of adherent cells on lymphokine activated killer cells. Cell Immunol 110: 365

    Google Scholar 

  17. Itoh K, Shiiba K, Shimizu Y, Kumagai K (1985) Generation of activated killer (AK) cells by recombinant interleukin 2 (rIL 2) in collaboration with interferon-γ(IFN-γ). J Immunol 134: 3124

    Google Scholar 

  18. Itoh K, Tilden AB, Kumagai K, Balch CM (1985) Leu-11+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL2)-induced activated killer (AK) cells. J Immunol 134: 802

    Google Scholar 

  19. Krönke M, Leonard WJ, Depper JMG (1985) Sequential expression of genes involved in human T lymphocyte growth and differentiation. J Exp Med 161: 1593

    Google Scholar 

  20. Lau AS, Hannigan GE, Freedman MH, Williams BRG (1986) Regulation of interferon receptor expression in human blood lymphocytes in vitro and during interferon therapy. J Clin Invest 77: 1632

    Google Scholar 

  21. Leonard WJ, Depper JM, Uchiyama T, Smith KA, Waldmann TA, Greene WC (1982) A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor. Nature 300: 267

    Google Scholar 

  22. Lifson J, Raubitschek A, Benike C, Koth K, Ammann A, Sondel P, Engleman E (1986) Purified interleukin-2 induces proliferation of fresh human lymphocytes in the absence of exogenous stimuli. J Biol Response Mod 5: 61

    Google Scholar 

  23. Lindemann R, Shau H, Ramsdell F, Bohman R, Golub SH (1987) Generation of cytotoxic lymphocytes from non-cytotoxicl-leucine methyl ester (LME) treated PBL with IL-2. Fed Proc 46: 1226

    Google Scholar 

  24. London L, Perussia B, Trinchieri G (1986) Induction of proliferation in vitro of resting human natural killer cells: IL-2 induces into cell cycle most peripheral blood NK cells, but only a minor subset of low density T cells. J Immunol 137: 3845

    Google Scholar 

  25. Malkovsky M, Jíra M, Madar J, Malkovska V, Loveland B, Asherson GL (1987) Generation of lymphokine-activated killer cells does not require DNA synthesis. Immunology 60: 471

    Google Scholar 

  26. Maluish AE, Ortaldo JR, Conlon JC, Sherwin SA, Leavitt R, Strong DM, Weirnik P, Oldham RK, Herberman RB (1983) Depression of natural killer cytotoxicity after in vivo administration of recombinant leukocyte interferon. J Immunol 131: 503

    Google Scholar 

  27. Neckers LM, Cossman J (1983) Transferrin receptor induction in mitogen-stimulated human T lymphocytes is required for DNA synthesis and cell division and is regulated by interleukin 2. Proc Natl Acad Sci USA 80: 3494

    Google Scholar 

  28. Ortaldo JR, Mantovani A, Hobbs D, Rubinstein M, Peska S, Herberman RB (1983) Effects of several species of human leukocyte interferon on cytotoxic activity of NK lymphocytes. Int J Cancer 31: 285

    Google Scholar 

  29. Ortaldo JR, Mason AT, Gerard JP, Henderson LE, Farrar W, Hopkins III RF, Herberman RB, Rabin H (1984) Effects of natural and recombinant IL2 on regulation of IFNγ production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects. J Immunol 133: 779

    Google Scholar 

  30. Phillips JH, Lanier LL (1986) Dissection of the lymphokineactivated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis. J Exp Med 164: 814

    Google Scholar 

  31. Pross HF, Baines MG, Rubin P, Shragge P, Patterson MS (1981) Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity. J Clin Immunol 1: 51

    Google Scholar 

  32. Ramsdell FJ, Shau H, Golub SH (1988) Role of proliferation in LAK cell development. Cancer Immunol Immunother 26: 139

    Google Scholar 

  33. Rosenberg SA, Lotze MT, Muul LM, Leitman S, Chang AE, Ettinghausen SE, Matory YL, Skibber JM, Shiloni E, Vetto JT, Seipp CA, Simpson C, Reichert CM (1985) Observations on the systemic administration of autologous lymphokine-activated cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med 313: 1485

    Google Scholar 

  34. Rosenberg SA, Spiess PJ, Lafreniere R (1986) A new approach to the adoptive immunotherapy of cancer with tumorinfiltrating lymphocytes. Science 223: 1318

    Google Scholar 

  35. Rosenberg SA, Schwarz SL, Spiess PJ (1988) Combination immunotherapy for cancer: synergistic antitumor interactions of interleukin-2, alpha interferon, and tumor-infiltrating lymphocytes. J Natl Cancer Inst 80: 1393

    Google Scholar 

  36. Sawada H, Abo T, Sugawara S, Kumagai K (1988) Prerequisite for the induction of lymphokine-activated killer cells from T lymphocytes. J Immunol 140: 3668

    Google Scholar 

  37. Shau H, Golub SH (1985) Depletion of NK cells with the lysosomotropic agentl-leucine methyl ester and the in vitro generation of NK activity from NK precursor cells. J Immunol 134: 1136

    Google Scholar 

  38. Shau H, Shen D, Golub SH (1986) The role of transferrin in natural killer cell and IL-2-induced cytotoxic cell function. Cell Immunol 97: 121

    Google Scholar 

  39. Spina CA, Fahey JL, Durkos-Smith D, Dorey F, Sarna G (1983) Suppression of natural killer cell cytotoxicity in the peripheral blood of patients receiving interferon therapy. J Biol Response Mod 2: 458

    Google Scholar 

  40. Sutherland R, Delia D, Schneider C, Newman R, Kemshead J, Greaves M (1981) Ubiquitous cell-surface glycoprotein in tumor cells is proliferation-associated receptor for transferrin. Proc Natl Acad Sci USA 78: 4515

    Google Scholar 

  41. Trinchieri G, Matsumoto-Kobayashi M, Clark SC, Seehra J, London L, Perussia B (1984) Response of resting human peripheral blood natural killer cells to interleukin 2. J Exp Med 160: 1147

    Google Scholar 

  42. Vose BM, Bonnard GD (1983) Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. I. The effect of lectin on the proliferative frequency and cytotoxic activity of cultured lymphoid cells. J Immunol 130: 687

    Google Scholar 

  43. Vose BM, Riccardi C, Bonnard GD, Herberman RB (1983) Limiting dilution analysis of the frequency of human T cell and large granular lymphocytes proliferating in response to interleukin 2. II. Regulatory role of interferon on proliferative and cytotoxic precursors. J Immunol 130: 768

    Google Scholar 

  44. Zoon KC, Nedden DZ, Hu R, Arnheiter H (1986) Analysis of the steady state binding, internalization, and degradation of human interferon-α2. J Biol Chem 261: 4993

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Surgical Oncology, Department of Surgery, UCLA School of Medicine, 54-140 Center for Health Sciences, 90024-1782, Los Angeles, CA, USA

    Yutaka Tokuda, Nobuo Ebina & Sidney H. Golub

Authors
  1. Yutaka Tokuda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nobuo Ebina
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sidney H. Golub
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This work was supported in part by USPHS grant CA34442. Y. T. is a UCLA visiting scientist from the Department of Surgery, School of Medicine, Tokai University, Kanagawa, Japan and recipient of a fellowship from the University of California Cancer Research Coordinating Committee. N. E. is a UCLA visiting scientist from the Department of Surgery, School of Medicine, Tohoku University, Sendai, Japan

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tokuda, Y., Ebina, N. & Golub, S.H. The inhibitory effect of human interferon α on the generation of lymphokine-activated killer activity. Cancer Immunol Immunother 30, 205–212 (1989). https://doi.org/10.1007/BF01665006

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01665006

Keywords

Search

Navigation